The Food and Drug Administration approved Moderna’s mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February

The decision caps a seven-month process that included a rare refusal to consider the shot.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading